E-Rare-3

Program Temat konkursu Data otwarcia Data zamknięcia
E-Rare-3 Badania obejmujące choroby rzadkie 05.12.2015

01.02.2017
pre-proposals
02.06.2017
full proposals

Zakres konkursu:
The research projects have to focus on the pre-clinical development of therapeutic approaches in suitable existing animal or cell models.
Therapeutic approaches can include:
1. Cell-based therapy (e.g. somatic cell therapy, cell-based regenerative medicine, tissue engineering, therapies based on combination of cells with scaffolds or substrates, etc.)
2. Gene therapy (e.g. transfer of nucleic acids for therapeutic purposes including DNA, RNA, oligonucleotides, etc.)
3. Pharmacological therapy (e.g. use of chemicals or biopharmaceuticals including repurposing approaches, high throughput screening of molecules, etc.)

Kraje partnerskie: Austria, Belgia, Finlandia, Francja, Grecja, Hiszpania, Izrael, Japonia, Kanada, Łotwa, Niemcy, Polska, Rumunia, Szwajcaria, Turcja, Węgry, Włochy
Więcej informacji: http://www.ncbr.gov.pl/programy-miedzynarodowe/era-net-co-fund/e-rare-3/aktualnosci/art,4756,e-rare-3-call-for-proposals-2017-for-european-research-projects-for-rare-diseases-jtc-2017-uruchomienie-trzeciego-konkursu.html